Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa followed by hp-HMG versus recombinant FSH in young poor ovarian responders
2013-000583-29Phase 3Completed
- Sponsor
- UZ Brussel
- Start
- Mar 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in female infertility and poor ovarian response (POR) comparing Corifollitropin alfa followed by hp-HMG with Recombinant FSH (2 arms). Primary endpoint: Ongoing pregnancy rate. Started Mar 2013; status: completed.
02
Drugs
corifollitropin alfamenotropinsrecombinant human follicle stimulating hormone
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on 2013-000583-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000583-29.